In a note, analyst Marko Kozul of Leerink Swann provided week-over-week IMS script trends for Biogen's (BIIB) MS drug Tecfidera ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE